REGNREGENERON PHARMACEUTICALS, INC.vs its industry peers
A metric-by-metric comparison of REGENERON PHARMACEUTICALS, INC. against its industry peers — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REGNThis | — | 21.3x#1 | — | — | 1.0%#4 | 2.1%#4 | 24.9%#3 | 13.4%#4 | 9.2%#4 | — | 47.6%#2 | — |
| VRTX | $142.8B#3 | 32.8x#3 | 7.1x#1 | 11.9x#3 | 8.9%#2 | 838.1%#2 | 34.8%#1 | 19.5%#3 | 25.0%#2 | — | 32.4%#4 | — |
| AMGN | $250.1B#1 | 28.7x#2 | 21.4x#3 | 6.8x#1 | 10.0%#1 | 88.5%#3 | 24.7%#4 | 66.0%#1 | 15.1%#3 | — | 58.2%#1 | 2.0%#1 |
| GILD | $207.9B#2 | — | 15.9x#2 | 7.1x#2 | 2.4%#3 | 1672.9%#1 | 34.0%#2 | 65.3%#2 | 25.7%#1 | — | 42.7%#3 | 1.9%#2 |
Peer set: Tickwind's hand-curated industry grouping. Values from SEC filings + delayed prices; ranks are sorted positions within this group only — descriptive, not a rating or advice. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice